Table 2 General information and clinical presentations of the cohort participated in this study

1

F

60

Hypertension/palpitations

2.1

1

2.8

4.4

60

4

–

–

2

F

32

Palpitations/dyspnea/fatigue/chest pain/syncope/anemia

1.1

0.9

–

4.4

40–45

–

–

–

3

M

16

Palpitations/dyspnea/fatigue/chest pain/gastrointestinal disorder/high cholesterol/allergy

3.2

0.9

3.45

4.29

60

3

–

 + 

4

M

58

Chest pain/hypertension/high cholesterol/muscular pain

1.6

0.86

3.9

5.3

20

4.5

N/A

N/A

5

F

43

Palpitations/dyspnea/abdominal edema/ischemia

1.5

0.91

3.52

4.65

15–20

5.2

–

–

6

M

8

Hypertension/palpitations

2.2

1

2.6

4.4

40–45

4.1

–

–

7

F

28

Fatigue/palpitations/hypertension

2.2

N/A

N/A

N/A

45

N/A

N/A

–

8

F

30

Hypertension/dyspnea/fatigue

1.8

0.7

2.5

4.3

45–50

3.1

N/A

–

9

M

26

Chest pain/dyspnea

0.9

0.8

5.8

6.8

10

4.1

–

–

10

F

7

Musculoskeletal disorder/Infectious disease

N/A

N/A

N/A

N/A

10–15

N/A

N/A

N/A

11

F

10

Dyspnea/palpitations/kidney problem

N/A

N/A

5.6

6.2

10

N/A

N/A

N/A

12

M

37

Cardiovascular disease/respiratory disease

0.8

0.8

5.8

6.4

10

N/A

N/A

N/A

13

M

24

Hypertension/high blood lipid/high triglyceride/fatigue/palpitations/dyspnea/fainting

0.9

0.9

6.1

7.7

15

4.7

N/A

N/A

14

M

2

Dyspnea/fatigue/chest pain/hypertension/liver disease/cardiac edema

1.5

N/A

N/A

N/A

55

N/A

N/A

N/A